Hospira Can't Block Generic Precedex, Judge Rules
A Maryland federal judge on Friday said the U.S. Food and Drug Administration's recent approval of generic versions of Hospira Inc.'s blockbuster sedative Precedex wasn't arbitrary or capricious, finding that the...To view the full article, register now.
Already a subscriber? Click here to view full article